Sorel-Tracy, Canada

Patrice Arpin

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2004-2006.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Patrice Arpin

Introduction

Patrice Arpin is a notable inventor based in Sorel-Tracy, CA. He has made significant contributions to the field of chemistry, particularly in the development of methods for synthesizing important chemical compounds. With a total of 2 patents, Arpin's work has implications for the treatment of neurological and psychological disorders.

Latest Patents

One of Arpin's latest patents is a method for preparing indan-1,3-dicarboxylic acid. This method focuses on creating compounds that serve as useful intermediates in the synthesis of aryl fused azapolycyclic compounds, which are potential agents for treating various neurological and psychological conditions. Another significant patent involves the purification of 2-methoxy-5-trifluoromethoxybenzaldehyde. This process details a method where the oil is converted to an amine through a reaction with nitroaniline, followed by isolation and conversion back to the original oil.

Career Highlights

Patrice Arpin is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.

Collaborations

Some of Arpin's coworkers include Timothy J N Watson and Mark Christopher Guzman. Their collaboration fosters a creative environment that encourages innovation and the development of new ideas.

Conclusion

Patrice Arpin's contributions to the field of chemistry through his patents and work at Pfizer Corporation highlight his role as an influential inventor. His innovative methods have the potential to advance treatments for significant health issues.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…